0001740279-18-000001.txt : 20180522 0001740279-18-000001.hdr.sgml : 20180522 20180522160055 ACCESSION NUMBER: 0001740279-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180522 DATE AS OF CHANGE: 20180522 EFFECTIVENESS DATE: 20180522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Incysus Therapeutics, Inc. CENTRAL INDEX KEY: 0001740279 IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312981 FILM NUMBER: 18852407 BUSINESS ADDRESS: STREET 1: 79 MADISON AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (646) 820-8474 MAIL ADDRESS: STREET 1: 79 MADISON AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001740279 Incysus Therapeutics, Inc. 79 MADISON AVENUE NEW YORK NY NEW YORK 10016 (646) 820-8474 DELAWARE None None Corporation true 2018 William Ho 79 Madison Avenue New York NY NEW YORK 10016 Executive Officer Director Thomas Cirrito 79 Madison Avenue New York NY NEW YORK 10016 Director Travis Whitfill 79 Madison Avenue New York NY NEW YORK 10016 Director Biotechnology Decline to Disclose 06b false 2018-05-07 false true false 0 8000000 4757530 3242470 false 13 0 0 0 false Incysus Therapeutics, Inc. /s/ William Ho William Ho Chief Executive Officer 2018-05-22